Effect of transjugular intrahepatic portosystemic shunt placement on renal function: A 7-year, single-center experience

Journal of Vascular and Interventional Radiology

Volumn 21, Issue 9, 2010, Pages 1370-1376

  Anderson, Curtis L ^a   Saad, Wael E A ^a   Kalagher, Sean D ^a   Caldwell, Steven ^a   Sabri, Saher ^a   Turba, Ulku C ^a   Matsumoto, Alan H ^a   Angle, John F ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; IODINATED CONTRAST MEDIUM;

ADULT; ARTICLE; CHRONIC LIVER DISEASE; CREATININE BLOOD LEVEL; DIALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEPATORENAL SYNDROME; HOSPITALIZATION; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT INDICATION;

ADULT; AGED; BIOLOGICAL MARKERS; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RECOVERY OF FUNCTION; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VIRGINIA;

EID: 77956183706     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2010.05.009     Document Type: Article

References (23)

1. L. Colombato The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension J Clin Gastroenterol 41 Suppl 3 2007 S344 S351
2. W.B. Crenshaw, F.D. Gordon, and N.J. McEniff Severe ascites: efficacy of the transjugular intrahepatic portosystemic shunt in treatment Radiology 200 1996 185 192
3. K.P. Moore, and G.P. Aithal Guidelines on the management of ascites in cirrhosis Gut 55 Suppl 6 2006 vi1 vi12
4. A.P. Betrosian, B. Agarwal, and E.E. Douzinas Acute renal dysfunction in liver diseases World J Gastroenterol 13 2007 5552 5559
5. A.L. Gerbes, V. Gulberg, T. Waggershauser, J. Holl, and M. Reiser Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites Hepatology 28 1998 683 688
6. W. Wong, P. Liu, L. Blendis, and F. Wong Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites Am J Med 106 1999 315 322
7. P. Michl, V. Gulberg, M. Bilzer, T. Waggershauser, M. Reiser, and A.L. Gerbes Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: Effects in patients with organic or functional renal failure Scand J Gastroenterol 35 2000 654 658
8. A. Ochs, M. Rossle, and K. Haag The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites N Engl J Med 332 1995 1192 1197
9. K.A. Brensing, J. Textor, and J. Perz Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study Gut 47 2000 288 295
10. M. Guevara, P. Gines, and J.C. Bandi Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems Hepatology 28 1998 416 422
11. F. Wong, L. Pantea, and K. Sniderman Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome Hepatology 40 2004 55 64
12. Z.J. Haskal, C.R. Rees, E.J. Ring, R. Saxon, and D. Sacks Reporting standards for transjugular intrahepatic portosystemic shunts J Vasc Interv Radiol 14 Suppl 2003 S419 S426
13. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470
14. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2 Suppl 1 2002 S1 S266
15. P.S. Kamath, and W.R. Kim The Model for End-stage Liver Disease (MELD) Hepatology 45 2007 797 805
16. P.S. Kamath, R.H. Wiesner, and M. Malinchoc A model to predict survival in patients with end-stage liver disease Hepatology 33 2001 464 470
17. A.J. Stanley, D.N. Redhead, I.A. Bouchier, and P.C. Hayes Acute effects of transjugular intrahepatic portosystemic stent-shunt (TIPSS) procedure on renal blood flow and cardiopulmonary hemodynamics in cirrhosis Am J Gastroenterol 93 1998 2463 2468
18. D.S. Sherman, D.N. Fish, and I. Teitelbaum Assessing renal function in cirrhotic patients: problems and pitfalls Am J Kidney Dis 41 2003 269 278
19. P. Gines, M. Guevara, V. Arroyo, and J. Rodes Hepatorenal syndrome Lancet 362 2003 1819 1827
20. R. Jalan, E.H. Forrest, D.N. Redhead, J.F. Dillon, and P.C. Hayes Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man? Gut 40 1997 664 670
21. F. Lang, E. Tschernko, and E. Schulze Hepatorenal reflex regulating kidney function Hepatology 14 1991 590 594
22. K. Tanaka, T. Matsuda, H. Morita, and H. Hosomi Depressed sensitivity of the hepatoportal NaCl receptors in rats with carbon tetrachloride-induced liver cirrhosis Am J Physiol 269 Suppl 1995 R1390 R1395
23. R.M. Merion, R.A. Wolfe, D.M. Dykstra, A.B. Leichtman, B. Gillespie, and P.J. Held Longitudinal assessment of mortality risk among candidates for liver transplantation Liver Transpl 9 2003 12 18